Collagen Patents (Class 530/356)
-
Patent number: 8198245Abstract: The present invention provides compositions comprising isolated human collagen, isolated human elastin and a pharmaceutically acceptable carrier wherein the human elastin is substantially insoluble in water with a molecular weight greater than 100 kDa. The present invention further provides methods and kits for soft tissue augmentation.Type: GrantFiled: July 24, 2008Date of Patent: June 12, 2012Assignee: Humacyte, Inc.Inventors: Laura Niklason, Yuling Li, Juliana Blum, Shannon Dahl, Geoffrey Erickson, Frank Zeigler
-
Patent number: 8198408Abstract: A method of preparing porous collagen matrices directly from connective tissues using an acidic solution substantially free of salt.Type: GrantFiled: July 27, 2009Date of Patent: June 12, 2012Assignees: National Cheng Kung University, Life Fusion, LLC.Inventor: Lynn L. H. Huang
-
Publication number: 20120141707Abstract: A biocompatible, resorbable biphasic collagen membrane having a first area of relatively higher tensile strength and stiffness and lower porosity and a second area of relatively lower tensile strength and stiffness and higher porosity, and a method of manufacturing the such a membrane.Type: ApplicationFiled: February 5, 2010Publication date: June 7, 2012Applicant: Osseous Technologies of AmericaInventors: David Cheung, William Knox, Jay Malmquist, Edwin Shors, Dennis Smiler
-
Publication number: 20120141575Abstract: The invention relates to collagen for use in the treatment of inflammatory and degenerative skin diseases and damage to the skin connected therewith, such as in particular in the treatment of psoriasis, dermatitis, neurodermitis, rosacea, urticaria (hives), pruritus (itching), skin eczema and actinic keratosis. In particular, the invention relates to freeze-dried collagen in the form of layered dressings, sheets, pads or masks for the aforementioned use.Type: ApplicationFiled: November 29, 2011Publication date: June 7, 2012Applicant: DR. SUWELACK SKIN & HEALTH CARE AGInventors: Anja Kassner, Martin Trautmann, Sabine Gütt
-
Patent number: 8188230Abstract: A composition comprising a purified collagen-like polypeptide suitable as a peptizer, said polypeptide comprising [Gly-X-Y]n repeats, wherein Gly stands for glycine, X and Y represent any amino acid and n is an integer and selected such that the length of the [Gly-X-Y]n repeat is at least 2.5 kDa and wherein the amino acid sequence of said [Gly-X-Y]n repeats comprises more than 4 different amino acids and wherein said purified polypeptide is free of helix structure.Type: GrantFiled: May 25, 2007Date of Patent: May 29, 2012Assignee: Fuji Film Manufacturing Europe B.V.Inventors: George Valentino Van Heerde, Alexis Comelus Van Rijn, Jan Bastiaan Bouwstra, Frederik Anton De Wolf, Andreas Mooibroek, Marc Willem Theodoor Werten, Richèle Deodata Wind, Tanja Jacoba Van Den Bosch
-
Patent number: 8188229Abstract: This invention includes malleable, biodegradable, fibrous compositions for application to a tissue site in order to promote or facilitate new tissue growth. One aspect of this invention is a fibrous component that provides unique mechanical and physical properties. The invention may be created by providing a vessel containing a slurry, said slurry comprising a plurality of natural or synthetic polymer fibers and at least one suspension fluid, wherein the polymer fibers are substantially evenly dispersed and randomly oriented throughout the volume of the suspension fluid; applying a force, e.g., centrifugal, to said vessel containing said slurry, whereupon said force serves to cause said polymer fibers to migrate through the suspension fluid and amass at a furthest extent of the vessel, forming a polymer material, with said polymer material comprising polymer fibers of sufficient length and sufficiently viscous, interlaced, or interlocked to retard dissociation of said polymer fibers.Type: GrantFiled: February 14, 2011Date of Patent: May 29, 2012Assignee: Kensey Nash BVF Technology, LLCInventors: Timothy A. Ringeisen, William Christian Wattengel
-
Patent number: 8173776Abstract: The invention concerns a recombinant CBE gelatin and recombinant gelatins having multimers of the CBE monomer sequence that are of particular use in several applications involving cell attachment such as in cell culture work and applications involving cell cultures of anchor dependent cells and also in a variety of medical applications.Type: GrantFiled: December 2, 2011Date of Patent: May 8, 2012Assignee: Fujifilm Manufacturing Europe B.V.Inventors: Arjo Lysander De Boer, Hendrik Van Urk, Jan Bastiaan Bouwstra, Peter Franciscus Theresius Maria Van Asten
-
Patent number: 8168151Abstract: This invention provides organic/inorganic composite biomaterials constituted by composites of hydroxyapatite and collagen and having an average fiber length of 60 ?m or longer, and a process for producing the same in which the calcium ion and phosphate ion concentrations in the reaction vessel are optimized through regulation of the concentration of a starting material and the flow rate. The organic/inorganic composite biomaterials have mechanical strength and a biodegradation rate suitable for artificial bones through the introduction of crosslinking therein.Type: GrantFiled: September 19, 2002Date of Patent: May 1, 2012Assignee: Japan Science and Technology AgencyInventors: Junzo Tanaka, Masanori Kikuchi, Noriichi Ito, Yoshinobu Mandai
-
Patent number: 8158756Abstract: The invention concerns a recombinant CBE gelatin and recombinant gelatins having multimers of the CBE monomer sequence that are of particular use in several applications involving cell attachment such as in cell culture work and applications involving cell cultures of anchor dependent cells and also in a variety of medical applications.Type: GrantFiled: February 21, 2008Date of Patent: April 17, 2012Assignee: Fujifilm Manufacturing Europe B.V.Inventors: Arjo Lysander De Boer, Hendrik Van Urk, Jan Bastiaan Bouwstra, Peter Franciscus Theresius Maria Van Asten
-
Publication number: 20120089084Abstract: A plasma coating device for treating a wound comprises a plasma chamber having: one or more electrodes, a gas supply inlet, a plasma outlet exposed to ambient pressure, and an ignition system operatively connected to the electrodes for providing a non-thermal equilibrium plasma within the plasma chamber. An aerosol delivery system is operable to introduce a bioresorbable material as an aerosol into the plasma, to produce a coating on the wound surface.Type: ApplicationFiled: June 15, 2010Publication date: April 12, 2012Inventors: Joe O'Keeffe, Peter Dobbyn, John O'Donoghus, Liam O'Neil
-
Publication number: 20120070466Abstract: Disclosed are compositions comprising collagen covalently bound to particles, wherein covalent bonds are formed between reactive groups of the collagen and reactive groups of the particles, and wherein the particles have an average particle diameter ranging from 20 to 1000 nanometers. Also disclosed are various methods that utilize the compositions.Type: ApplicationFiled: June 7, 2011Publication date: March 22, 2012Applicant: UNIVERSITY OF MISSOURI, OFFICE OF IPAInventors: Anthony Harris, Jonathan Thompson, Rebecca Rone, Sheila Grant, David Grant
-
Publication number: 20120065376Abstract: A method of generating atelocollagen is disclosed. The method comprises contacting a human telopeptide-comprising collagen with a protease selected from the group consisting of neutrase, subtilisin, ficin recombinant human trypsin and recombinant human pepsin, wherein said human telopeptide-comprising collagen is expressed in a non-animal cell, thereby generating the atelocollagen. Compositions comprising the atelocollagen generated thereby are also disclosed.Type: ApplicationFiled: October 26, 2008Publication date: March 15, 2012Applicant: CollPlant Ltd.Inventors: Oded Shoseyov, Hanan Stein, Michal Rosenthal, Or Dgany, Tamar Haya Tal, Amit Yaari
-
Publication number: 20120059152Abstract: As a result of dedicated research, the present inventors have successfully invented a collagen gene construct which can be easily purified and maintains a triple helix structure equivalent to that of naturally-occurring collagen while having a low molecular weight. Specifically, one-step purification by affinity purification is enabled because CR-D (a signal peptide) has a carbohydrate recognition domain. By substituting a portion of a human collagen structural gene of the present invention with the collagen-like structural gene portion of MBL, a low-molecular-weight collagen which maintains a triple helix structure and is thermally stable can be obtained with high purity and in large quantities.Type: ApplicationFiled: December 22, 2009Publication date: March 8, 2012Inventors: Yusuke Suzuki, Hiroshi Tahara, Keiichi Yamamoto, Yuzuru Kitahara, Yasuhiko Suzuki
-
Publication number: 20120053322Abstract: Tissue matrices having anti-microbial properties are provided. In certain embodiments, the tissue matrices include cationic anti-microbial agents that form a stable bond with the tissue matrices without adversely affecting the biologic properties of the tissue matrices.Type: ApplicationFiled: August 25, 2011Publication date: March 1, 2012Inventors: Rick T. Owens, Mike Liu, Yong Mao
-
Publication number: 20120053080Abstract: Methods for detecting cancer as well as methods of diagnosis of cancer by detecting proteins secreted into biological fluids are disclosed The invention was first applied to detecting proteins secreted into serum and urine However, it is understood that the methods have broader application to developing tools and systems for detecting proteins secreted into other biological fluids such as, but not limited to, saliva, spinal fluid, seminal fluid, vaginal fluid, and ocular fluid Reliable detection of proteins secreted into biological fluids provided by embodiments of the methods will enable more timely and accurate detection and diagnosis of cancer.Type: ApplicationFiled: February 19, 2010Publication date: March 1, 2012Inventors: Juan Cui, J. David Puett, Seulgi Hong, Ying Xu
-
Publication number: 20120046737Abstract: Implantable biocompatible polymeric medical devices include a substrate with an acid or base-modified surface which is subsequently modified to include click reactive members.Type: ApplicationFiled: February 19, 2010Publication date: February 23, 2012Inventors: Nadya Belcheva, Ferass Abuzaina, Amin Elachchabi, Mbiya Kapiamba, Ahmad Robert Hadba
-
Patent number: 8119599Abstract: A method of treatment of native, non-denatured tissue to increase resistance to tearing, fissuring, rupturing, and/or delamination, comprising the step of: contacting at least a portion of the tissue with an effective amount of a reagent that increases crosslinks in the tissue.Type: GrantFiled: October 17, 2007Date of Patent: February 21, 2012Assignee: Orthopeutics, L.P.Inventors: Thomas P. Hedman, Paul Slusarewicz
-
Patent number: 8119596Abstract: A composition for treating damaged tissue and promoting healthy tissue growth, healing and tissue regeneration, wherein said composition comprises an extracellular matrix compound, a surface-active lipid, one or more enantiomerically pure L-amino acids or glycine, a hydrophilic surfactant with a high HLB, as well as vitamins, minerals or trace elements. Not only does it maintain good health, but the components are non-intrusive, bio-safe, non-coalescent and can mimic normally occurring stem-cells within a body. When applied to diseased tissues, the subject compositions can stimulate, facilitate, and accelerate protein synthesis for the regeneration of diseased organs and tissues. The healing efficacy of these tissue components gives us further appreciation of the protective action of human tissue over and above and other than the immune protective system or perhaps an integral component part of the immune system.Type: GrantFiled: August 31, 2010Date of Patent: February 21, 2012Assignee: Immunopath Profile, Inc.Inventor: Leonard S. Girsh
-
Publication number: 20120040119Abstract: The invention relates to novel collagen materials and, specifically, collagen membranes, tubes and threads. Said materials combine enhanced properties of resilience and strength. The invention also relates to a method for preparing collagen materials using acid fibrous collagen comprising coagulation and, optionally, cross-linking of the collagen in the presence of ammonia gas.Type: ApplicationFiled: April 28, 2010Publication date: February 16, 2012Applicant: BIOM'UPInventors: Christian Gagnieu, Patricia Forest, Sylvain Picot
-
Publication number: 20120027732Abstract: This invention relates to collagen formulations. More particularly, this invention relates to thermoreversible collagen formulations and methods of their use and preparation.Type: ApplicationFiled: July 27, 2011Publication date: February 2, 2012Inventor: Sherry L. Voytik-Harbin
-
Publication number: 20120029150Abstract: The present disclosure relates to a method of forming fibers. First and second precursors, each possessing a core and at least one functional group known to have click reactivity, are mixed. The mixed precursors are then extruded under heat to cross-link during fiber production.Type: ApplicationFiled: February 22, 2010Publication date: February 2, 2012Inventors: Ahmad Robert Hadba, Sébastien Ladet
-
Publication number: 20120027872Abstract: Apparatus is provided for sealing a vascular puncture by causing a reduction in the circumference of the puncture tract through delivery of a closure agent into tissue surrounding the puncture tract. A resultant inflammatory response and volumetric increase cause the tissue to swell into the puncture tract, thereby sealing it.Type: ApplicationFiled: June 30, 2011Publication date: February 2, 2012Applicant: ABBOTT LABORATORIES VASCULAR ENTERPRISES, LTD.Inventors: Stevan Nielsen, Bodo Quint, Randolf Von Oepen, Kenneth J. Michlitsch, Gerd Seibold, Tommy Conzelmann, Ib Erling Joergensen
-
Publication number: 20120027814Abstract: A method for bonding a polymeric fiber to tissue is provided which includes providing a polymeric fiber having a plurality of tissue reactive members linked to a surface of the fiber via a specific binding pair, and contacting the polymeric fiber to biological tissue, to covalently bond the fiber to the tissue.Type: ApplicationFiled: July 27, 2011Publication date: February 2, 2012Inventor: Sébastien Ladet
-
Patent number: 8105629Abstract: The present invention relates to a process of producing a collagen gel comprising collagen fibers cross-linked with each other by a cross-linking agent on the way of fibrosis of collagen, and a collagen gel comprising the cross-linked collagen fibers obtained by the process. The collagen gel comprising cross-linked collagen fibers of the present invention has high strength and thermal stability and can be widely used as cell carriers and medical materials.Type: GrantFiled: February 24, 2005Date of Patent: January 31, 2012Assignee: Ihara & Company Ltd.Inventors: Shunji Yunoki, Nobuhiro Nagai
-
Publication number: 20120021063Abstract: To provide a collagen/elastin crosslinked material capable of satisfactorily corresponding to various uses such as medical materials including an artificial dermis and scaffolding materials for cell culture. The collagen/elastin crosslinked material is obtained by crosslinking a fish-derived collagen and a fish-derived elastin, and is fully capable of corresponding to various uses such as medical materials including an artificial dermis and scaffold material for cell culture.Type: ApplicationFiled: March 10, 2010Publication date: January 26, 2012Applicants: MARUHA NICHIRO FOODS, INC., HIROSAKI UNIVERSITY, SAPPORO MEDICAL UNIVERSITYInventors: Yoshitaka Matsumoto, Takatoshi Yotsuyanagi, Shinichi Suto, Yoshifumi Yamaya, Yosuke Hoshino, Kazunari Nishimura, Tomoko Koga, Hiroyuki Enari
-
Publication number: 20120022233Abstract: The invention relates to a highly pure collagen, its use as an implant and a method for its preparation, the method comprising subjecting a sample comprising collagen to at least one alkaline treatment step in an alkaline solution at a pH>12 and at least one cleaning step with at least one chaotropic agent.Type: ApplicationFiled: March 24, 2010Publication date: January 26, 2012Inventors: Roman Breiter, Ludwig Koerber, Silke Schwarz
-
Publication number: 20120010728Abstract: Methods for shaping tissue matrices are provided. The methods can be used to produce shaped tissue products that retain desired biologic properties without using chemical crosslinking agents.Type: ApplicationFiled: July 7, 2011Publication date: January 12, 2012Inventors: Wendell Sun, Gary Monteiro
-
Patent number: 8092823Abstract: Described are osteogenic implants that include a first implant material covered at least in part by a second implant material carrying an osteogenic protein such as a bone morphogenic protein. The first implant material can comprise a mineral and provide an inner scaffolding portion for supporting bone ingrowth, and the second implant material can comprise a collagen or other sponge carrier covering the first implant material and having a liquid osteogenic protein formulation imbibed therein. Related implant materials and methods of preparation and use constitute additional aspects of the invention.Type: GrantFiled: January 8, 2010Date of Patent: January 10, 2012Assignee: Warsaw Orthopedic, Inc.Inventors: William F. McKay, Scott D. Boden, Neil B. Beals
-
Publication number: 20110318421Abstract: The present disclosure is directed to surface functionalized ceramic nanoparticles. The method for producing the surface functionalized ceramic nanoparticles generally includes at least four distinct steps: 1) synthesis of an amphiphilic surfactant having the desired surface functionality, 2) formation of mixed solvent microstructured solution with the surfactant, 3) synthesis of the desired ceramic within the microstructured solution, and 4) chemical attachment of the surfactant to the ceramic nanoparticle. The composition of the surface functionalized nanoparticle comprises a lipophilic component, a hydrophilic component, a chelating agent and a ceramic forming component.Type: ApplicationFiled: August 8, 2011Publication date: December 29, 2011Inventor: Edward Parsonage
-
Patent number: 8084579Abstract: A composition comprising a purified collagen-like polypeptide suitable as a peptizer, said polypeptide comprising [Gly-X-Y] repeats, wherein Gly stands for glycine, X and Y represent any amino acid and n is selected such that the length of the [Gly-X-Y] repeat is at least 2.5 kDa and wherein the amino acid sequence of said polypeptide comprises more than 4 different amino acids and wherein said purified polypeptide is free of helix structure.Type: GrantFiled: January 15, 2003Date of Patent: December 27, 2011Assignee: Fuji Film Manufacturing Europe B.V.Inventors: George Valentino Van Heerde, Alexis Comelus Van Rijn, Jan Bastiaan Bouwstra, Frederik Anton De Wolf, Andreas Mooibroek, Marc Willem Theodoor Werten, Richèle Deodata Wind, Tanja Jacoba Van Den Bosch
-
Publication number: 20110306755Abstract: The present invention provides compositions comprising human placental telopeptide collagen, methods of preparing the compositions, methods of their use and kits comprising the compositions. The compositions, kits and methods are useful, for example, for augmenting or replacing tissue of a mammal.Type: ApplicationFiled: August 18, 2011Publication date: December 15, 2011Inventors: Mohit Bhatia, Chris Lugo, Qian Ye, James W. Edinger
-
Publication number: 20110306754Abstract: The present disclosure relates to the present disclosure relates to a method of fabricating an aligned polymer containing a bonded substrate and related compositions. The method involved placing a polymer in solution which is capable of alignment wherein the polymer is also bound to a selected substrate. This may then be followed by placing the polymer solution in an electrochemical cell wherein the polymer solution is in contact with at least one electrode and applying an electric field/voltage to the polymer solution and generating a pH gradient wherein the polymer and bonded substrate positions at the isoelectric point of the polymer in solution.Type: ApplicationFiled: June 11, 2010Publication date: December 15, 2011Applicant: SOUTHWEST RESEARCH INSTITUTEInventors: Xingguo Cheng, Vasiliki Z. Poenitzsch
-
Patent number: 8076294Abstract: The present invention relates to a collagen-related polypeptide (CRP) having hydrophobic amino acid groups at the N- and C-termini capable of non-covalent self-assembly into collagen mimetic triple helices and fibrils thereof and the synthesis, methods of use and compositions thereof.Type: GrantFiled: July 25, 2008Date of Patent: December 13, 2011Assignee: Advanced Technologies and Regenerative Medicine, LLC.Inventors: William A. Kinney, Mabel Alarnino Cejas, Bruce E. Maryanoff, Thomas Matalenas, Chunlin Yang
-
Publication number: 20110301131Abstract: The invention discloses an implant suitable for delivery of at least one drug, the implant comprising a fibrillar collagen matrix having, as measured in Example 1, a viscosity of greater than 100 mPas, optionally greater than 103 mPas, further optionally greater than 106 mPas, still further optionally greater than 109 mPas when a collagen dispersion formed from 140 mg of the fibrillar collagen matrix is dispersed in 25 ml of 2 mM HCl at a pH of less than 3.5 and at a temperature of 30.0+/?0.5° C.Type: ApplicationFiled: November 6, 2009Publication date: December 8, 2011Inventors: Joan Fitzpatrick, David Prior
-
Patent number: 8067374Abstract: Disclosed is an adhesive hemostatic agent based on non-blood constituents including DOPA, able to strongly adhere to collagen fibers. The agent includes an antifibrinolytic agent in addition to an esterified atelocollagen which is non-immunogenic and may become positively charged thereon such that the adhesive hemostatic agent has no possibility of mediating particular diseases or viral infections (HIV, HCV, HBV, CMV, etc), unlike conventional agents comprising blood constituents, and readily binds to negatively charged platelets at high adhesive strength, thus inducing quick blood coagulation. Also, provided is a method for preparing the same.Type: GrantFiled: April 15, 2009Date of Patent: November 29, 2011Assignee: Dalim Biotech Co., Ltd.Inventor: Hwal Suh
-
Publication number: 20110288274Abstract: The present invention identified a recombinant synthetic collagen containing a triple helical backbone protein produced in a prokaryotic expression system where the protein contains at least one ‘inserted’ biologically active sequence(s).Type: ApplicationFiled: July 19, 2010Publication date: November 24, 2011Inventors: Brooke H. Russell, Magnus Hook, Mariah S. Hahn, Elizabeth M. Cosgriff-Hernandez, Neungseon Seo, Marvin Xuejun Xu
-
Publication number: 20110288026Abstract: The invention is directed to formation and use of electroprocessed collagen, including use as an extracellular matrix and, together with cells, its use in forming engineered tissue. The engineered tissue can include the synthetic manufacture of specific organs or tissues which may be implanted into a recipient. The electroprocessed collagen may also be combined with other molecules in order to deliver substances to the site of application or implantation of the electroprocessed collagen. The collagen or collagen/cell suspension is electrodeposited onto a substrate to form tissues and organs.Type: ApplicationFiled: March 21, 2011Publication date: November 24, 2011Inventors: David G. Simpson, Gary L. Bowlin, Gary E. Wnek, Peter J. Stevens, Marcus E. Carr, Jamil A. Matthews, Saravanamoorthy Rajendran
-
Patent number: 8043627Abstract: The invention relates to an osteogenic composite matrix consisting of collagen and non-collagen components of an extracellular matrix (ECM-components), to a method for producing said matrix, to a method for producing an implant or a scaffold for tissue engineering which is provided with a coating formed by said osteogenic composite matrix and is used for stimulating and accelerating a hard tissue formation such as, for example. The implant osseointegration in bones. The inventive osteogenic composite matrix comprises a collagen and at least one non-collagen ECM component or the derivatives thereof, wherein the collagen component consists of non-crosslinked collagen fibers produced by fibrillogenesis and the non-collagen ECM component or the derivatives thereof are integrated into said collagen fibers.Type: GrantFiled: October 2, 2009Date of Patent: October 25, 2011Assignee: Nexilis AGInventors: Dieter Scharnweber, Hartmut Worch, Susanne Bierbaum
-
Publication number: 20110256303Abstract: A process for cross-linking proteins, according to which the crosslinking agent is dihydroxyacetone and the proteins are chosen from proteins from animal tissues, from milk or from blood, such as in particular casein, gelatin or collagen; proteins from cereals, such as in particular maize, wheat or rice proteins; protein from high-protein plants, such as in particular pea, alfalfa, lupin, barley, millet or sorghum proteins; proteins from oleaginous plants, such as in particular soybean proteins, for instance soybean cakes, rapeseed or flax proteins, for instance rapeseed cakes, sunflower, groundnut or cotton proteins; and proteins from tubers, such as in particular from potato or manioc.Type: ApplicationFiled: June 27, 2011Publication date: October 20, 2011Applicant: ROQUETTE FRERESInventors: Daniel WILS, Catherine FOUACHE
-
Patent number: 8039591Abstract: Flowable graft materials are provided which comprise collagen powder and a liquid in an amount sufficient to impart a flowable consistency to the material. The graft materials are sufficiently formable and pliable so as to provide both superior contact with and easier access to a surgical site than typical, more rigid grafts such as collagen sheets. These flowable materials may also be in a fluidized, paste-like and/or gel-like state and may be moldable and/or ejectable. The flowable collagen materials reduce and/or eliminate post implantation problems associated with other materials, e.g. synthetic dural sealants (hemostasis products), such as product swelling after application and implantation. The flowable graft materials are particularly useful as a dural graft.Type: GrantFiled: April 21, 2009Date of Patent: October 18, 2011Assignee: Codman & Shurtleff, Inc.Inventor: Robert E. Sommerich
-
Patent number: 8039225Abstract: Various embodiments include methods for diagnosing and treating medical conditions that involve an autoimmune response to connective tissue such as collagen found in organs such as the lung. In one method pulmonary disease and disorders such as Idiopathic Pulmonary Fibrosis (IPF) are diagnosed by analyzing fluid or tissue samples obtained from a patient for evidence of an autoimmune response to various types of collagen including, for example, Type V. One type of assay for evidence of an autoimmune response to Type V collagen comprises the steps of obtaining a fluid or tissue sample from a patient, contacting at least a portion of the sample with antigen to anti-Type V collagen antibody and monitoring the mixture of sample and antigen for changes indicative of the presence of anti-Type V collagen in the sample. Another embodiment includes treating pulmonary diseases such as IPF by administering a therapeutically effective dose of epitopes of various collagens including Type V collagen.Type: GrantFiled: April 7, 2011Date of Patent: October 18, 2011Assignee: Indiana University Research & Technology CorporationInventors: David S. Wilkes, Michael Klemsz
-
Publication number: 20110245466Abstract: The invention concerns the method of production of a polyanionic macromolecule which is a protein built, among others, form polar amino acids (such as lysine, arginine, aspartic acid, glutamic acid), characteristic in that, that as a result of the reaction between amine groups and the cyclic anhydride of dicarboxylic acid, the charge changes towards more negatively charged carrier. This reaction gives rise to better therapeutic properties of macromolecules modified in this way.Type: ApplicationFiled: October 23, 2009Publication date: October 6, 2011Inventors: Janusz Boratynski, Mohamed Salah Omar Megahed, Urszula Kanska, Dmitry Nevozhay, Joanna Wietrzyk
-
Patent number: 8030448Abstract: Disclosed is a peptide trimer in which three peptides of the same chain length having a repeating unit as a fundamental structure represented by the formula: -(-Gly-X-Y-)- wherein X and Y each represent any amino acid residue are tethered to one another such that they are shifted relative to one another in the backbone direction. The peptide trimer is capable of forming a polypeptide having a collagen-like triple helix structure. A method of producing the peptide trimer of the invention and a collagen-like molecular aggregate having a triple helix structure comprised of the peptide trimer unit of the invention are also provided.Type: GrantFiled: February 3, 2005Date of Patent: October 4, 2011Assignees: Techno Network Shikoku Co., Ltd., Nippi, IncorporatedInventor: Takaki Koide
-
Patent number: 8022038Abstract: It is an object of the present invention to provide a composition for promoting the production of type I collagen by human skin fibroblasts, and the present invention relates to a composition for promoting type I collagen production containing silybin and a peptide that promotes collagen production (peptide having an amino acid sequence of Gly-Pro-Hyp, Gly-His-Lys, Lys-Thr-Thr-Lys-Ser (SEQ ID NO: 1) or Gly-Glu-Pro-Arg (SEQ ID NO: 2).Type: GrantFiled: July 20, 2006Date of Patent: September 20, 2011Assignee: Fancl CorporationInventors: Satoshi Miyata, Yukari Umino
-
Publication number: 20110217750Abstract: An activatable functionalised Nth generation dendrimer having: a core comprising a first monomer having at least two carboxylic acid functional groups; and N successive generations, where N=0 to 10, wherein each generation comprises: a second monomer having at least two alcohol functional groups, wherein at least one alcohol group is bonded to a carboxylic acid group of the first monomer of the prior generation, and an additional first monomer attached to a second alcohol function group of said second monomer of that generation; and the final generation having attached thereto at said second alcohol functional group of said second monomer, a moiety having a dicarboxylic acid functional group, activatable by treatment with a carboxylic acid activating reagent such that reactivity of the carboxylic acid functional group is increased. The dendrimer, when activated, may be used in applications such as polymer crosslinking and/or nanoshell production.Type: ApplicationFiled: March 19, 2009Publication date: September 8, 2011Applicant: NATIONAL UNIVERSITY OF IRELAND, GALWAYInventors: Abhay Pandit, Gildas Rethore, Hemantkumar Naik
-
Publication number: 20110217460Abstract: A material derived from sea cucumber collagen fibrils is suitable for use in corneal replacements or as an implantable contact lens. To produce material, the collagen fibrils are centrifuged into orthogonal stacks of lamellae comprised of aligned fibrils. The resulting structure is a transparent film of arbitrary thickness very similar in structure to mammalian corneal tissue.Type: ApplicationFiled: May 13, 2011Publication date: September 8, 2011Applicants: University of South Florida, Shriners Hospitals for ChildrenInventors: W. GARRETT MATTHEWS, August Heim, Thomas J. Koob
-
Patent number: 8013121Abstract: The present invention concerns isolated collagen, the method for its production, and isolation of the collagen from collagen-containing tissues, as well as the use of the isolated collagen in a biomatrix as an in vitro test system, tissue replacement or organ replacement.Type: GrantFiled: May 30, 2007Date of Patent: September 6, 2011Assignee: Fraunhofer-Gesellschaft zur Foerderung der Angewandten Forschung E.V.Inventors: Xin Xiong, Heike Mertsching, Steffen Rupp, Herwig Brunner
-
Publication number: 20110207671Abstract: The present invention relates to double-crosslinked collagen materials, methods for preparing double-crosslinked collagen materials, and methods of using double-crosslinkedType: ApplicationFiled: August 21, 2009Publication date: August 25, 2011Applicant: FibroGen, Inc.Inventors: Robert C. Chang, David R. Olsen, Jame W. Polarek, Kim E. Williams
-
Patent number: 8003611Abstract: The present invention aims at providing a biomaterial composite not having risks of pathogen infection and unfavorable side effects such as rejection response. According to the invention, there is provided a biomaterial composite, which comprises a polypeptide and a calcium phosphate compound, said peptide comprising the units of Formulas (I) to (III): [—(OC—(CH2)m—CO)p-(Pro-Y-Gly)n-]a??(I) [—(OC—(CH2)m—CO)q-(z)r-]b??(II) [—HN—R—NH—]c??(III) wherein m, p, q, Y, n, Z, r, R, a, b and c are as defined in the specification. The composite of the invention is particularly suitable for an artificial bone due to its high biocompatibility, high endurance and mechanical strength. Further, the invention can provide a process of the composite according to the invention can for preparation of the composite having excellent mechanical characteristics by a simple procedure.Type: GrantFiled: March 14, 2006Date of Patent: August 23, 2011Assignee: National University Corporation Nara Institute of Science and TechnologyInventors: Masanobu Kamitakahara, Masao Tanihara, Chikara Ohtsuki, Shinichi Ogata
-
Publication number: 20110190813Abstract: A method of crosslinking a protein or peptide for use as a biomaterial, the method comprising the step of irradiating a photoactivatable metal-ligand complex and an electron acceptor in the presence of the protein or peptide, thereby initiating a crosslinking reaction to form a 3-dimensional matrix of the biomaterial.Type: ApplicationFiled: August 14, 2008Publication date: August 4, 2011Inventors: Alan George Brownlee, Christopher Malcolm Elvin, Jerome Anthony Werkmeister, John Alan Maurice Ramshaw, Charles Mark Lindall